Katha Pollitt: Stiffed

subject to debate by Katha Pollitt

[from the June 13, 2005 issue]

Penises were all over the news as I sat down to write this column. On May 22 faces blushed scarlet in New York State when it came to light that over the past five years Medicaid has handed out free Viagra to 198 sex criminals. Apparently the state thought federal rules required no less. The next day, researchers released a study showing excellent results for Johnson & Johnson's dapoxetine, a drug that prevents premature ejaculation and intensifies the male orgasm. True, rapists' access to taxpayer-funded stiffies vanished within hours, and they will probably have to buy their own dapoxetine too. But you have to admit, men are moving right along, sexually. They have drugs to help them get up and stay in and get out in a shower of sparks, and an array of private and public health plans to pay for these fleshly maneuvers: Last year Medicaid laid out approximately $38 million for impotence drugs; Medicare will start providing them for seniors next year at an estimated cost of nearly $2 billion over the following decade. Even the Defense Department covers them. Need I add that men don't have to worry that their pharmacist will ask to see a marriage license or plug their name into the sex offender registry before handing over those little blue pills?

No, the double standard still waves over the nation's bedrooms. The only new birth control method coming up soon is actually a nostalgia item, the Today sponge, beloved by Seinfeld's Elaine, which will be returning to drugstores later this year. Two decades into the AIDS epidemic, the only woman-controlled means of protection against HIV--now the leading cause of death among black women age 25-34--is the aesthetically repulsive, cumbersome and hard-to-find female condom. Hormone replacement therapy, promoted since the 1950s as the fountain of feminine youth and sexual vitality, looks to be mostly hype, with the possibility of heart attack, stroke and breast or ovarian cancer.